Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

SAN DIEGO, Jan. 07, 2024 -- Singular Genomics Systems, Inc. , a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, today...

Related Keywords

Dan Budwick ,Matt Clawson ,Singular Genomics Systems Inc ,Nasdaq ,Genomics Systems ,Max Read ,Drew Spaventa ,Chief Executive Officer ,Singular Genomic ,Singular Genomics Systems ,Singular Genomics ,Quarterly Report ,Markets ,